Ae Wealth Management LLC Horizon Therapeutics Public LTD CO Transaction History

Ae Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$62.39 - $113.8 $30,196 - $55,079	-484 Reduced 13.02%	3,233 $367,000
Q3 2022 Oct 25, 2022	SELL	$58.92 - $84.67 $740,860 - $1.06 Million	-12,574 Reduced 77.18%	3,717 $230,000
Q2 2022 Aug 03, 2022	BUY	$79.4 - $116.36 $6,590 - $9,657	83 Added 0.51%	16,291 $1.3 Million
Q1 2022 Apr 18, 2022	BUY	$86.42 - $109.81 $51,592 - $65,556	597 Added 3.82%	16,208 $1.71 Million
Q4 2021 Jan 20, 2022	BUY	$98.56 - $119.91 $80,227 - $97,606	814 Added 5.5%	15,611 $1.68 Million

Q3 2021 Nov 01, 2021	SELL	$91.91 - $110.37 $5,330 - $6,401	-58 Reduced 0.39%	14,797 $1.62 Million
Q2 2021 Jul 21, 2021	SELL	$86.24 - $95.92 $82,531 - $91,795	-957 Reduced 6.05%	14,855 $1.39 Million
Q1 2021 Apr 27, 2021	BUY	$71.83 - $95.48 $1.14 Million - $1.51 Million	15,812 New	15,812 $1.46 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.